Skip to content
Clinical Trials – home

Clinical Research & Healthcare GmbH

Research site

Germany Achenweg 1, Unterstein, 83471 Schoenau A. Koenigssee, Germany

  • 1 trial recruiting
  • Meningitis meningococcal · Conjunctivitis allergic · Meningococcal infection
  • Children and adolescents

About Specializations

Clinical Research & Healthcare GmbH in Schoenau A. Koenigssee, Germany specialises in clinical trials of conditions such as Meningitis meningococcal, Conjunctivitis allergic, Meningococcal infection, Pneumococcal immunisation, and other specialisations. This site conducts important research.

Main research areas of the site

Pediatric Respiratory Health

The medical center is at the forefront of research in pediatric respiratory health, focusing on innovative treatments for children suffering from recurrent respiratory tract infections (RTIs) with wheezing lower respiratory illness (wLRI). The center's research aims to improve the quality of life for young patients by reducing the frequency and severity of these infections.

  • Recurrent Respiratory Tract Infections
  • Wheezing Lower Respiratory Illness
  • Innovative Pediatric Treatments

Through its pioneering work, the center contributes significantly to the development of effective therapeutic strategies, offering hope to families affected by these challenging conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Achenweg 1, Unterstein83471 Schoenau A. KoenigsseeGermany
Recruiting now
1 trial
Conditions studied
4

More sites in Schoenau A. KoenigsseeGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

6 clinical trials

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited

Study on the Safety and Immune Response of MenABCWY Vaccine and Drug Combination in Healthy Infants with Meningococcal Infections

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000017986
  • Sponsor:GlaxoSmithKline Biologicals

Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:Pneumococcal oligosaccharide serotype 18C conjugated to CRM197
  • Sponsor:Sanofi Vaccines US Inc.

Study on the Safety and Immune Response of MenABCWY Vaccine in Healthy Adolescents Aged 11-14 with Meningococcal Meningitis

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN
  • Sponsor:GlaxoSmithKline Biologicals

Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
  • Sponsor:Sanofi Pasteur
Countries:GermanyGermany
  • Participants:0–17 years
  • Sponsor:OM Pharma SA
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.